Literature DB >> 18778587

Type 2 diabetes mellitus in children and adolescents: where do we stand with drug treatment and behavioral management?

Nicole S Nader1, Seema Kumar.   

Abstract

Type 2 diabetes, once considered a disease of adults, is a growing problem in the pediatric population. The emergence of type 2 diabetes in this age group has paralleled the epidemic of childhood obesity. Lifestyle modifications represent first-line therapy for children and adolescents with type 2 diabetes. However, many children and adolescents go on to require treatment with oral medications or insulin for optimal control. A paucity of data exist regarding the optimal treatment regimen for children and adolescents with type 2 diabetes. Further research regarding the treatment of type 2 diabetes in youth is required.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18778587     DOI： 10.1007/s11892-008-0066-2

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


  35 in total

Review 1.  Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop.

Authors:  George Alberti; Paul Zimmet; Jonathan Shaw; Zachary Bloomgarden; Francine Kaufman; Martin Silink
Journal:  Diabetes Care       Date:  2004-07       Impact factor: 19.112

2.  Standards of medical care in diabetes--2006.

Authors: 
Journal:  Diabetes Care       Date:  2006-01       Impact factor: 19.112

3.  Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome.

Authors:  Mark R Palmert; Catherine M Gordon; Alex I Kartashov; Richard S Legro; S Jean Emans; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

Review 4.  Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective.

Authors:  A Fagot-Campagna; D J Pettitt; M M Engelgau; N R Burrows; L S Geiss; R Valdez; G L Beckles; J Saaddine; E W Gregg; D F Williamson; K M Narayan
Journal:  J Pediatr       Date:  2000-05       Impact factor: 4.406

5.  Diabetic ketoacidosis among obese African-American adolescents with NIDDM.

Authors:  O Pinhas-Hamiel; L M Dolan; P S Zeitler
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

6.  Type 2 diabetes in children and adolescents. American Diabetes Association.

Authors: 
Journal:  Diabetes Care       Date:  2000-03       Impact factor: 19.112

Review 7.  Type 2 diabetes mellitus in children and youth: a new epidemic.

Authors:  Francine Ratner Kaufman
Journal:  J Pediatr Endocrinol Metab       Date:  2002-05       Impact factor: 1.634

8.  Incidence of diabetes in youth in the United States.

Authors:  Dana Dabelea; Ronny A Bell; Ralph B D'Agostino; Giuseppina Imperatore; Judith M Johansen; Barbara Linder; Lenna L Liu; Beth Loots; Santica Marcovina; Elizabeth J Mayer-Davis; David J Pettitt; Beth Waitzfelder
Journal:  JAMA       Date:  2007-06-27       Impact factor: 56.272

Review 9.  Acute and chronic complications of type 2 diabetes mellitus in children and adolescents.

Authors:  Orit Pinhas-Hamiel; Philip Zeitler
Journal:  Lancet       Date:  2007-05-26       Impact factor: 79.321

10.  Prevention and treatment of type 2 diabetes mellitus in children, with special emphasis on American Indian and Alaska Native children. American Academy of Pediatrics Committee on Native American Child Health.

Authors:  Sheila Gahagan; Janet Silverstein
Journal:  Pediatrics       Date:  2003-10       Impact factor: 7.124
View more
  3 in total

1.  Early phase drugs and biologicals clinical trials on worldwide leading causes of death: a descriptive analysis.

Authors:  Rafael Dal-Ré
Journal:  Eur J Clin Pharmacol       Date:  2011-04-05       Impact factor: 2.953

2.  Effect of type 2 diabetes mellitus caveolin-3 K15N mutation on glycometabolism.

Authors:  Yiyuan Huang; Yufeng Deng; Lina Shang; Lihui Yang; Juanjuan Huang; Jing Ma; Xianshan Liao; Hui Zhou; Jing Xian; Guining Liang; Qin Huang
Journal:  Exp Ther Med       Date:  2019-08-02       Impact factor: 2.447

3.  Glucose Uptake Activities of Bis (2, 3-Dibromo-4, 5-Dihydroxybenzyl) Ether, a Novel Marine Natural Product from Red Alga Odonthaliacorymbifera with Protein Tyrosine Phosphatase 1B Inhibition, In Vitro and In Vivo.

Authors:  Feng Xu; Fang Wang; Zhenhong Wang; Wenshan Lv; Wei Wang; Yangang Wang
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.